- Home
- / Dashenlin Pharmaceutical Group
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Dashenlin Pharmaceutical Group financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥14.7
2024-10-29
Market Capitalization
¥16.5 B
2024-10-29
Revenue
¥26.7 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.6B | 10.8B | 14.2B | 16.2B | 20.7B | 23.8B | 25.7B | 26.7B |
| Cost of goods sold | 5.2B | 6.7B | 9.0B | 10.4B | 13.2B | 15.7B | 17.4B | 18.1B |
| Gross profit | 3.6B | 4.3B | 5.5B | 6.3B | 8.0B | 8.7B | 9.0B | 9.3B |
| Gross profit margin, % | 40.1% | 39.1% | 39.0% | 38.4% | 36.6% | 34.9% | 34.8% | |
| Operating expense total | 2.8B | 3.3B | 4.0B | 5.0B | 6.1B | 6.6B | 7.2B | 6.9B |
| Depreciation and amortization | 117.7M | 153.9M | 194.0M | 229.5M | 231.8M | 272.8M | 343.0M | 371.9M |
| EBITDA | 842.2M | 1.1B | 1.6B | 1.3B | 1.8B | 2.1B | 1.8B | 2.4B |
| EBITDA margin, % | 9.9% | 11.0% | 8.2% | 8.9% | 8.8% | 7.0% | 8.8% | |
| EBIT | 728.4M | 933.7M | 1.4B | 1.2B | 1.6B | 1.8B | 1.5B | 2.0B |
| EBIT margin, % | 8.6% | 10.0% | 7.4% | 7.8% | 7.6% | 6.0% | 7.5% | |
| Interest income | 15.6M | 24.9M | 49.5M | 68.3M | 63.1M | 85.2M | 81.3M | 69.3M |
| Interest expense | 24.0M | 32.1M | 11.5M | 32.3M | 48.2M | 66.2M | 84.1M | 77.3M |
| Pre tax profit | 719.6M | 919.5M | 1.4B | 1.0B | 1.4B | 1.6B | 1.3B | 1.8B |
| Income tax expense | 193.9M | 223.0M | 363.4M | 239.5M | 335.6M | 397.1M | 359.7M | 490.5M |
| Net Income | 525.7M | 696.5M | 1.1B | 804.4M | 1.1B | 1.2B | 979.9M | 1.4B |